‘FT’: Siemens Healthineers Acquires Novartis Company with Cancer Diagnostics Chemicals | 08.25.24

LONDON (dpa-AFX) – Siemens Healthineers has developed a new pharmaceutical division with radioactive chemicals for credit diagnostics. The German Medizintechnik group would cost the Schweizer more than 200 million euros, which the “Financial Times” (“FT”) in the Wochenende gave a stir with the trusted persons. The transaction itself can bring both the best results. It is so that the years have been completed.

Siemens Healthineers is one of the “FT” companies that continues its expansion in the United States. PET-Radiopharmaceutical-Arm the expansion into Europe